(Q43615891)

English

Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Dogné JM

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Wouters J

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Rolin S

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Michaux C

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Pochet L

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Durant F

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Delarge J

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Masereel B

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

669-680

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Thromboxane A2 and related prostaglandins in airways

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

New trends in thromboxane and prostacyclin modulators

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Antagonism of the human thromboxane A2 receptor by an anti-asthmatic agent AA-2414.

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Protein modelling for all

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Torasemide. A review of its pharmacological properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Synthesis and structure of the platelet aggregation factor thromboxane A2

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Pharmacology of L-655,240 (3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-indol-2-yl]2,2-dimethylpro pan oic acid); a potent, selective thromboxane/prostaglandin endoperoxide antagonist

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500)

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related c

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Antagonism of the TXA2 receptor by seratrodast: a structural approach

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction

1 reference

https://api.crossref.org/works/10.1211%2F0022357011775992

21 January 2018

Identifiers

10.1211/0022357011775992

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43615891&oldid=2108550459"